Neurology® Podcast

View Top 200 Chart

Back to Rankings Page

Health & Fitness
**Neurology® Podcast**

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Latest Episodes:

Delayed Recall - October 2013 - Headaches II Oct 01, 2013

Show notes

Post-traumatic headache, pediatric headache, and pseudotumor cerebri.

October 1 2013 Issue Sep 30, 2013

Show notes

1) Migraine and structural changes in the brain and 2) Topic of the month: Multiple sclerosis therapy and treatment. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jennifer Bickel interviews Dr. Messoud Ashina about his paper on migraine and structural changes in the brain. Dr. Adam Numis is reading our e-Pearl of the week about manganese neurotoxicity. In the next part of the podcast Dr. Mark Keegan interviews Dr. Paul O' Connor about teriflunomide for the treatment of multiple sclerosis. The participants had nothing to disclose except Drs. Ashima, Numis, Keegan, and O'Connor.Dr. Ashina serves as an Associate Editor of Cephalalgia; serves on the scientific advisory board for The Journal of Headache and Pain; is a consultant for ATI, Allergan, Inc., Amgen and Alder Biopharmaceuticals, Inc.; received honoraria for lecturing from Allergan Inc.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Keegan serves as Chief Editor of eMedicine and receives research support from Terumo BCT.Dr. O'Connor serves on the scientific advisory boards of Novartis Fingolimod Steering Committee, Sanofi-aventis Teriflunomide Steering Committee, BRAVO (laquinimod) study DMC-chairman, Genetech, Inc. Roche, Acetelion Pharmaceuticals Ltd, Receptos, Inc; received honoraria for attending two Advisory board meetings; served on the editorial advisory board for the MS Journal; serves as a consultant for Biogen Idec, Merck Serono, is currently a consultant for Teva Pharmaceutical Industries Ltd., Sanofi-aventis, Novartis; receives research support from Novartis, Sanofi-aventis, Roche, Biogen Idec, and from the MS Society of Canada as National Scientific and Clinical Advisor.

September 24 2013 Issue Sep 23, 2013

Show notes

1) The complexities of acute stroke decision-making and 2) Topic of the month: Living Legends Interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. Michel Shamy about his paper on the complexities of acute stroke decision-making. Dr. Roy Strowd is reading our e-Pearl of the week about Adie's tonic pupil. In the next part of the podcast Dr. Brett Kissela interviews Dr. Lou Caplan about his medical education and contributions to the field of neurology, interactions with C. Miller Fisher and advice to our younger listeners now beginning their careers. The participants had nothing to disclose except Drs. Kissela, Shamy, Strowd and Caplan.Dr. Kissela serves on scientific advisory board for Allergan, Inc.; has received funding for travel and speaker honoraria from Allergan, Inc.; has received research support from the NIH, will receive compensation from Reata Pharmaceuticals, Inc. for serving on the Event Adjudication Committee for the BEACON study, which they are sponsoring and provides medico-legal reviews.Dr. Shamy serves as an editorial board member of The Neurohospitalist; receives research support from Alberta Innovates Health Solutions Clinical Fellowship, H. Richard Tyler Award for Research in History of Neurology from the American Academy of Neurology.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Caplan serves as an editorial board member of Archives of Neurology; serves as co-editor of Reviews in Neurological Diseases and receive payment for Aruba monitoring.

September 17 2013 Issue Sep 16, 2013

Show notes

1) Helsinki model cutting stroke thrombolysis delays and 2) Topic of the month: Living Legends Interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Atte Meretoja about his paper on Helsinki model cutting stroke thrombolysis delays. Dr. Roy Strowd is reading our e-Pearl of the week about transient global amnesia. In the next part of the podcast Dr. Stacey Clardy interviews Dr. Vanda Lennon about establishing the Neuroimmunology Laboratory at the Mayo Clinic, her contribution to the field of neurology and advice to our younger listeners now beginning their careers. The participants had nothing to disclose except Drs. Southerland, Meretoja, Strowd, Clardy and Lennon.Dr. Southerland serves as Podcast Deputy Editor for Neurology® and serves as Clinical Research Advisor for Totier Technologies, Inc. Dr. Meretoja serves as an editorial board member of the International Journal of Stroke; receives research support from Sigrid Juselius Foundation, Biomedicum Helsinki Foundation and Finnish Medical Foundation.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.Dr. Lennon performs service testing for aquaporin-4 autoantibodies on behalf of Mayo Collaborative Service Inc., an agency of Mayo Foundation; receives royalties and license fee payments for the intellectual property: Marker for Neuromyelitis Optica; receives research support from the NIH.

September 10 2013 Issue Sep 09, 2013

Show notes

1) AAN paper on the top five choosing wisely recommendations and 2) Topic of the month: Living Legends Interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Gary Gronseth and Mr. Tom Getchius about the AAN paper on the top five choosing wisely recommendations. Dr. Roy Strowd is reading our e-Pearl of the week about schwannomatosis: more than just NF1 and NF2. In the next part of the podcast Dr. Farrah Mateen interviews Dr. Martin Samuels about his medical education and teaching contributions to the field of neurology and advice to our younger listeners now beginning their careers. The participants had nothing to disclose except Drs. Southerland, Gronseth, Mr. Getchius, Strowd and Mateen.Dr. Southerland serves as Podcast Deputy Editor for Neurology®.Dr. Gronseth serves on the editorial board of Neurology Now and receives research support from the American Academy of Neurology.Mr. Getchius is a full time employee of the American Academy of Neurology, spending 100% of his time directing the development and dissemination activities of AAN evidence- based guidelines and receives research support as Project Director of the CDC-RFA-DD10-1012 award.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Mateen has consulted for the World Health Organization, Global Polio Eradication Initiative, and Caritas.

September 3 2013 Issue Sep 02, 2013

Show notes

1) GABAB receptor autoantibody frequency in-service serological evaluation and 2) This week's topic: About Ted Burns about being diagnosed with a serious cancer. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Zsofia Hole interviews Dr. Andrew McKeon about his paper on GABAB receptor autoantibody frequency in-service serological evaluation. Dr. Roy Strowd is reading our e-Pearl of the week about Fazio-Londe syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Ted Burns about being diagnosed with a serious cancer and how he has gained insight into what it's like being a patient. The participants had nothing to disclose except Drs. McKeon, Strowd, Espay, and Burns.Dr. McKeon receives research support from the Guthy Jackson Charitable Foundation.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay is supported by the K23 career development award (NIMH, 1K23MH092735); has received grant support from CleveMed/Great Lakes Neurotechnologies, Davis Phinney Foundation, and Michael J Fox Foundation; is a consultant for Chelsea Therapeutics; serves on the scientific advisory boards for Solvay Pharmaceuticals, Inc., Abbott (now Abbie), Chelsea Therapeutics, TEVA Pharmaceutical Industries Ltd, Impax Pharmaceuticals, Merz Pharmaceuticals, LLC, Solstice Neurosciences, and Eli Lilly and Company, USWorldMeds; serves as Assistant Editor of Movement Disorders and on the editorial boards of The European Neurological Journal and Frontiers in Movement Disorders; serves on the speakers' bureaus of Novartis, UCB, TEVA Pharmaceutical Industries Ltd, American Academy of Neurology, Movement Disorder Society and receives royalties from Lippincott, Williams & Wilkins and Cambridge University Press.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals.

Delayed Recall - September 2013 - Headaches I Sep 01, 2013

Show notes

Migraine in women and cluster headaches

August 27 2013 Issue Aug 26, 2013

Show notes

1) Risk factors for dementia with Lewy bodies and 2) Topic of the month: Frontotemporal degeneration. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Geldmacher interviews Dr. Brendon Boot about his paper on risk factors for dementia with Lewy bodies. Dr. Adam Numis is reading our e-Pearl of the week about reversible cerebral vasoconstriction syndrome. In the next part of the podcast Dr. Brandy Matthews focuses her interview with Dr. Bill Seeley about therapeutics and future directions in frontotemporal degeneration. The participants had nothing to disclose except Drs. Geldmacher, Numis, Matthews and Seeley.Dr. Geldmacher serves as an editorial board member of Brain Injury; serves on a Data Safety Committee for GlaxoSmithKline; received research support from Baxter International Inc., Elan Corporation, Eisai Inc.; received honoraria for consulting from Abbvie, Janssen Alzheimer Immunotherapy, and Baxter International Inc. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Matthews receives research support from the NIH.Dr. Seeley serves as an editorial board member for Annuals of Neurology; served on the scientific advisory board for Bristol-Myers Squibb; is a consultant for Summer Street Research Partners; received speaker honorarium from Novartis Korea; received research support from the John Douglas French Alzheimer's Disease Foundation, Consortium for Frontotemporal Dementia Research; Tau Consortium, James S. McDonnell Foundation, Alzheimer's Disease Drug Foundation, Association for Frontotemporal Dementia and National Institute on Aging.

August 20 2013 Issue Aug 19, 2013

Show notes

1) Electronic media in neurology education and 2) Topic of the month: Frontotemporal degeneration. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Shaheen Lakhan about his paper on electronic media in neurology education. Dr. Adam Numis is reading our e-Pearl of the week about hemifacial spasm. In the next part of the podcast Dr. Brandy Matthews focuses her interview with Dr. Bill Seeley about diagnostic testing and genetics in frontotemporal degeneration. The participants had nothing to disclose except Drs. Lakhan, Numis, Matthews and Seeley.Dr. Lakhan serves on the editorial team for the Neurology® Resident and Fellow Section, serves as Associate Editor for BMC Research Notes and Journal of Medical Case Reports, BioMed Central, serves as an editorial board member of International Archives of Medicine, BioMed Central; serves on the scientific advisory board for OA Pain Medicine, OA Publishing London, Nanotechnology Research Foundation, National Science & Technology Education Partnership, International Physicians Advisory Council, International Cancer Advocacy Network; is a consultant for Global Neuroscience Initiative Foundation and receives research support from Global Neuroscience Initiative Foundation.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Matthews receives research support from the NIH.Dr. Seeley serves as an editorial board member for Annuals of Neurology; served on the scientific advisory board for Bristol-Myers Squibb; is a consultant for Summer Street Research Partners; received speaker honorarium from Novartis Korea; received research support from the John Douglas French Alzheimer's Disease Foundation, Consortium for Frontotemporal Dementia Research; Tau Consortium, James S. McDonnell Foundation, Alzheimer's Disease Drug Foundation, Association for Frontotemporal Dementia and National Institute on Aging.

August 13 2013 Issue Aug 12, 2013

Show notes

1) An index to identify stroke-related versus incidental patent foramen ovale in cryptogenic stroke and 2) Topic of the month: Frontotemporal degeneration. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. David Kent about his paper on using an index to identify stroke-related versus incidental patent foramen ovale in cryptogenic stroke. Dr. Adam Numis is reading our e-Pearl of the week about superior quadrantopia. In the next part of the podcast Dr. Brandy Matthews focuses her interview with Dr. Bill Seeley about clinical presentations and bedside evaluation in frontotemporal degeneration. The participants had nothing to disclose except Drs. Kent, Numis, Matthews and Seeley.Dr. Kent is a consultant for WL Gore Associates and receives research support from the NIH.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Matthews receives research support from the NIH.Dr. Seeley serves as an editorial board member for Annuals of Neurology; served on the scientific advisory board for Bristol-Myers Squibb; is a consultant for Summer Street Research Partners; received speaker honorarium from Novartis Korea; received research support from the John Douglas French Alzheimer's Disease Foundation, Consortium for Frontotemporal Dementia Research; Tau Consortium, James S. McDonnell Foundation, Alzheimer's Disease Drug Foundation, Association for Frontotemporal Dementia and National Institute on Aging.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected